Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial
Margaretha M. Visser, Sara Charleer, Steffen Fieuws, Christophe De Block, Robert Hilbrands, Liesbeth Van Huffel, Toon Maes, Gerd Vanhaverbeke, Eveline Dirinck, Nele Myngheer, Chris Vercammen, Frank Nobels, Bart Keymeulen, Chantal Mathieu, Pieter Gillard
Topics & Concepts
MedicineRandomized controlled trialWorryType 2 diabetesContinuous glucose monitoringType 1 diabetesDiabetes mellitusClinical trialClinical endpointPediatricsPhysical therapyInternal medicinePsychiatryEndocrinologyAnxietyDiabetes Management and ResearchMobile Health and mHealth ApplicationsDiabetes Management and Education